Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0 CHF
3.53 M CHF
224.83 M CHF
5.08 M
About Medartis Holding AG
Sector
Industry
CEO
Matthias Schupp
Website
Headquarters
Basel
Founded
1997
ISIN
CH0386200239
FIGI
BBG00K68NZ53
Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. It operates through the following geographical segments: EMEA, US, APAC, and LATAM. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MED is 80.1 CHF — it has decreased by −0.37% in the past 24 hours. Watch Medartis Holding AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Medartis Holding AG stocks are traded under the ticker MED.
MED stock has fallen by −5.88% compared to the previous week, the month change is a −12.17% fall, over the last year Medartis Holding AG has showed a 38.10% increase.
We've gathered analysts' opinions on Medartis Holding AG future price: according to them, MED price has a max estimate of 105.00 CHF and a min estimate of 86.00 CHF. Watch MED chart and read a more detailed Medartis Holding AG stock forecast: see what analysts think of Medartis Holding AG and suggest that you do with its stocks.
MED stock is 2.28% volatile and has beta coefficient of 1.16. Track Medartis Holding AG stock price on the chart and check out the list of the most volatile stocks — is Medartis Holding AG there?
Today Medartis Holding AG has the market capitalization of 998.44 M, it has increased by 1.16% over the last week.
Yes, you can track Medartis Holding AG financials in yearly and quarterly reports right on TradingView.
Medartis Holding AG is going to release the next earnings report on Mar 17, 2026. Keep track of upcoming events with our Earnings Calendar.
Medartis Holding AG revenue for the last half-year amounts to 122.05 M CHF, despite the estimated figure of 124.00 M CHF. In the next half-year revenue is expected to reach 143.70 M CHF.
MED net income for the last half-year is −1.45 M CHF, while the previous report showed 963.00 K CHF of net income which accounts for −250.57% change. Track more Medartis Holding AG financial stats to get the full picture.
No, MED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 18, 2025, the company has 949 employees. See our rating of the largest employees — is Medartis Holding AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medartis Holding AG EBITDA is 30.84 M CHF, and current EBITDA margin is 15.67%. See more stats in Medartis Holding AG financial statements.
Like other stocks, MED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medartis Holding AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medartis Holding AG technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medartis Holding AG stock shows the buy signal. See more of Medartis Holding AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.